Aquarius Surgical Technologies Inc.
ASTI
CNSX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -56.98% | -77.18% | -40.22% | -54.45% | -5.49% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -56.98% | -77.18% | -40.22% | -54.45% | -5.49% |
| Cost of Revenue | -63.25% | -74.35% | 145.28% | -45.71% | -29.94% |
| Gross Profit | -51.77% | -79.64% | -64.37% | -61.47% | 33.02% |
| SG&A Expenses | -46.46% | 45.25% | -23.17% | 11.24% | -8.52% |
| Depreciation & Amortization | -17.54% | -8.77% | -8.47% | 1.79% | 46.15% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -46.71% | 22.79% | -16.72% | 2.43% | -9.53% |
| Operating Income | 44.20% | -78.30% | 6.52% | -30.41% | 10.40% |
| Income Before Tax | -112.57% | -27.98% | -29.38% | -18.18% | -106.15% |
| Income Tax Expenses | -78.85% | -- | -- | -- | -- |
| Earnings from Continuing Operations | -106.45% | -27.98% | -29.38% | -16.98% | -112.96% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -106.45% | -27.98% | -29.38% | -16.98% | -112.96% |
| EBIT | 44.20% | -78.30% | 6.52% | -30.41% | 10.40% |
| EBITDA | 44.15% | -85.55% | 6.40% | -30.39% | 10.63% |
| EPS Basic | -106.78% | -28.57% | -31.11% | -18.00% | -110.71% |
| Normalized Basic EPS | 32.43% | -43.33% | -24.14% | -23.33% | 0.00% |
| EPS Diluted | -106.78% | -28.57% | -31.11% | -18.00% | -110.71% |
| Normalized Diluted EPS | 32.43% | -43.33% | -24.14% | -23.33% | 0.00% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.18% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |